Clinical Trials

Showing trials with last updates posted in 2024.

NCT04241588 | WITHDRAWN
0 participants

Assessment of Neural and Motor Performance

Study Type:
OBSERVATIONAL
Last Updated:
2024-09-03
Start Date:
2022-11-22
Completion:
2022-11-22
Conditions
  • Amniotic Band Syndrome
  • Upper Extremity Deformities, Congenital
Interventions
  • DEVICE
  • OTHER
No Results Yet
NCT04173507 | COMPLETED | PHASE2
47 participants

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-03
Start Date:
2020-02-14
Completion:
2021-11-24
Conditions
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
NCT04097340 | TERMINATED | NA
24 participants

Attention Training on Smartphones

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-03
Start Date:
2019-09-01
Completion:
2021-08-04
Conditions
  • Attention
  • Substance Use
Interventions
  • DEVICE
No Results Yet
NCT03971474 | COMPLETED | PHASE2
166 participants

Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-03
Start Date:
2019-05-28
Completion:
2022-04-14
Conditions
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page